Implications of the US Food and Drug Administration draft guidance for mitigating septic reactions from platelet transfusions
Blood Adv
.
2017 Jun 23;1(15):1142-1147.
doi: 10.1182/bloodadvances.2017008334.
eCollection 2017 Jun 27.
Authors
Bruce S Sachais
1
,
Sarai Paradiso
1
,
Donna Strauss
1
,
Beth H Shaz
1
Affiliation
1
New York Blood Center, New York, NY.
PMID:
29296756
PMCID:
PMC5728328
DOI:
10.1182/bloodadvances.2017008334
No abstract available